{
  "@context": [
    "file://domain/_contexts/base.jsonld",
    "file://domain/_contexts/medicine.jsonld"
  ],
  "@type": [
    "EducationalResource",
    "MedicalCondition"
  ],
  "@id": "health-sciences:medicine:pulmonology:pulm-005",
  "metadata": {
    "version": "4.0.0",
    "created": "2026-01-09T01:51:20.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent",
      "pulmonology-knowledge-base"
    ],
    "confidence": 0.96,
    "status": "validated",
    "modified": "2026-01-11T14:48:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/pulmonology",
    "type": "definition",
    "difficulty": "intermediate",
    "importance": "critical",
    "aku_id": "005",
    "keywords": [
      "community-acquired pneumonia",
      "CAP",
      "Streptococcus pneumoniae",
      "atypical pneumonia",
      "CURB-65",
      "PSI"
    ],
    "medical_specialty": "pulmonology",
    "clinical_context": "infectious_disease"
  },
  "content": {
    "title": "Community-Acquired Pneumonia (CAP)",
    "summary": "Acute infection of the lung parenchyma acquired outside of hospital or healthcare settings",
    "key_points": [
      "Most common pathogens: S. pneumoniae, H. influenzae, atypicals",
      "Severity assessment: PSI/PORT score or CURB-65",
      "Outpatient: amoxicillin or doxycycline; if comorbid: respiratory FQ or beta-lactam + macrolide",
      "Inpatient: beta-lactam (ceftriaxone) + macrolide or respiratory FQ alone",
      "MRSA/Pseudomonas coverage only with specific risk factors",
      "5-7 day duration adequate if clinical improvement"
    ],
    "statement": {
      "text": "Community-acquired pneumonia is an acute infection of the pulmonary parenchyma in a patient not recently hospitalized or residing in a long-term care facility. Diagnosis requires clinical symptoms plus radiographic infiltrate. Empiric antibiotic selection is based on severity and comorbidities.",
      "formal": "CAP = Clinical features (cough, fever, dyspnea) + Radiographic infiltrate + Severity assessment \u2192 Empiric antibiotics targeting likely pathogens"
    },
    "explanation": {
      "intuition": "Pneumonia is an infection filling the air sacs (alveoli) with pus and fluid, blocking oxygen exchange. The body responds with fever, cough, and increased breathing rate. Treatment with appropriate antibiotics clears the infection.",
      "key_insight": "Most CAP is caused by S. pneumoniae and atypical organisms. Empiric therapy must cover both. Don't add MRSA/Pseudomonas coverage unless specific risk factors present - this causes antibiotic resistance without benefit."
    },
    "definitions_glossary": {
      "community_acquired_pneumonia": "Pneumonia acquired outside hospital/healthcare settings",
      "CURB_65": "Severity score: Confusion, Urea >7, Resp rate \u226530, BP <90/60, age \u226565",
      "PSI_PORT": "Pneumonia Severity Index - predicts mortality, determines site of care",
      "typical_pathogens": "S. pneumoniae, H. influenzae, M. catarrhalis",
      "atypical_pathogens": "Mycoplasma, Chlamydophila, Legionella - intracellular, require macrolide/FQ",
      "respiratory_fluoroquinolone": "Levofloxacin, moxifloxacin - covers typical + atypical",
      "consolidation": "Airspace filling with inflammatory exudate visible on imaging",
      "lobar_pneumonia": "Infection limited to one lobe, typically bacterial",
      "bronchopneumonia": "Patchy infiltrates in multiple areas, often from bronchial spread",
      "walking_pneumonia": "Mild CAP, often atypical, ambulatory treatment",
      "empyema": "Pus in pleural space - complication of pneumonia",
      "parapneumonic_effusion": "Pleural fluid associated with pneumonia"
    }
  },
  "clinical_features": {
    "pathophysiology": {
      "mechanism": "Aspiration or inhalation of pathogens \u2192 colonization of lower respiratory tract \u2192 alveolar invasion \u2192 inflammatory response \u2192 exudate filling alveoli \u2192 impaired gas exchange",
      "host_defenses": "Cough reflex, mucociliary clearance, alveolar macrophages, IgA. Failure of defenses (smoking, aspiration, immunocompromise) increases risk."
    },
    "diagnostic_criteria": {
      "clinical_features": [
        "Cough (productive or dry)",
        "Fever",
        "Dyspnea",
        "Pleuritic chest pain",
        "Crackles on auscultation"
      ],
      "laboratory": [
        "Leukocytosis or leukopenia",
        "Elevated CRP, procalcitonin",
        "Sputum Gram stain and culture",
        "Blood cultures (if hospitalized)",
        "Legionella and pneumococcal urinary antigens"
      ],
      "imaging": "CXR with new infiltrate confirms diagnosis; CT if CXR unclear"
    },
    "severity_assessment": {
      "CURB_65": {
        "components": [
          "Confusion",
          "Urea >7 mmol/L (BUN >19)",
          "Respiratory rate \u226530",
          "Blood pressure <90/60",
          "Age \u226565"
        ],
        "scoring": {
          "0_1": "Outpatient",
          "2": "Short hospital or supervised outpatient",
          "3_5": "Hospitalize; \u22654 consider ICU"
        }
      },
      "PSI_PORT": {
        "class_I_II": "Low risk - outpatient (mortality <1%)",
        "class_III": "Consider short observation",
        "class_IV_V": "Hospitalize (mortality 8-30%)"
      },
      "severe_CAP": [
        "Need for vasopressors",
        "Need for mechanical ventilation",
        "Major ATS/IDSA criteria"
      ]
    },
    "treatment_options": {
      "outpatient_healthy": [
        "Amoxicillin 1g TID",
        "OR doxycycline 100mg BID",
        "Duration: 5 days"
      ],
      "outpatient_comorbid": [
        "Amoxicillin-clavulanate or cefpodoxime PLUS macrolide",
        "OR respiratory FQ monotherapy (levofloxacin, moxifloxacin)",
        "Duration: 5-7 days"
      ],
      "inpatient_non_severe": [
        "Ceftriaxone 1g daily + azithromycin 500mg daily",
        "OR respiratory FQ monotherapy",
        "Duration: 5 days if afebrile 48h, stable"
      ],
      "inpatient_ICU_severe": [
        "Ceftriaxone + azithromycin (or respiratory FQ)",
        "Add vancomycin/linezolid if MRSA risk",
        "Add anti-pseudomonal if Pseudomonas risk"
      ],
      "special_pathogens": {
        "Legionella": "FQ preferred; macrolide alternative; 7-10 days",
        "MRSA_risk_factors": "Prior MRSA, IV drug use, severe necrotizing - add vancomycin/linezolid",
        "Pseudomonas_risk": "Structural lung disease, frequent steroids/antibiotics"
      }
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Community-Acquired Pneumonia"
    },
    "altLabel": [
      {
        "@language": "en",
        "@value": "CAP"
      },
      {
        "@language": "en",
        "@value": "Pneumonia"
      }
    ],
    "definition": {
      "@language": "en",
      "@value": "Acute lower respiratory tract infection with pulmonary infiltrate acquired outside of hospital or healthcare settings"
    },
    "notation": "pulm-005"
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "385093006",
      "uri": "http://snomed.info/id/385093006",
      "description": "Community acquired pneumonia",
      "matchType": "exactMatch"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "J18.9",
      "description": "Pneumonia, unspecified organism",
      "matchType": "broadMatch"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "J13",
      "description": "Pneumonia due to Streptococcus pneumoniae",
      "matchType": "narrower"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "MeSH",
      "codeValue": "D011014",
      "uri": "http://id.nlm.nih.gov/mesh/D011014",
      "description": "Pneumonia",
      "matchType": "broadMatch"
    }
  ],
  "pedagogical": {
    "target_audience": [
      "medical_students",
      "internal_medicine_residents",
      "hospitalists",
      "primary_care"
    ],
    "estimated_time": "40min",
    "difficulty_curve": 0.68,
    "learning_objectives": [
      "Diagnose CAP clinically and radiographically",
      "Calculate CURB-65 for severity assessment",
      "Select empiric antibiotics based on setting and severity",
      "Identify indications for MRSA and Pseudomonas coverage",
      "Determine appropriate duration of therapy"
    ],
    "clinical_pearls": [
      "Procalcitonin can help differentiate bacterial from viral - may guide antibiotic duration",
      "5 days is adequate if afebrile 48h and clinically stable",
      "Don't add MRSA/Pseudomonas coverage without specific risk factors",
      "Respiratory FQ are overprescribed - reserve for penicillin allergy or comorbidities",
      "Legionella: think of it with GI symptoms, hyponatremia, CNS symptoms"
    ],
    "board_yield": {
      "usmle_step2": "Very High",
      "internal_medicine_boards": "Critical"
    }
  },
  "relationships": {
    "skos:related": [
      {
        "@id": "health-sciences:medicine:pulmonology:pulm-006",
        "@type": "skos:Concept",
        "skos:prefLabel": "Hospital-Acquired Pneumonia"
      },
      {
        "@id": "health-sciences:medicine:infectious-disease",
        "@type": "skos:Concept",
        "skos:prefLabel": "Infectious Disease"
      }
    ],
    "owl:sameAs": [
      "http://snomed.info/id/385093006",
      "http://www.wikidata.org/entity/Q12192"
    ]
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-11T14:48:00.000Z",
    "sources": [
      {
        "source": "Metlay JP, et al. Diagnosis and Treatment of Adults with CAP. Am J Respir Crit Care Med 2019",
        "type": "clinical_guideline",
        "year": 2019,
        "confidence": 1.0
      },
      {
        "source": "IDSA/ATS CAP Guidelines 2019",
        "type": "clinical_guideline",
        "year": 2019,
        "confidence": 1.0
      }
    ]
  },
  "quality_assessment": {
    "CQS": 0.94,
    "completeness": 0.95,
    "accuracy": 0.96,
    "clarity": 0.94,
    "pedagogical_quality": 0.93,
    "ontology_alignment": 0.94,
    "last_assessment": "2026-01-11T14:48:00.000Z",
    "assessor": "quality-enhancement-agent"
  },
  "owl:sameAs": "http://dbpedia.org/resource/Community-acquired_pneumonia",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q12192"
}